Purpose. While some micro-organisms, such as Staphylococcus aureus, are clearly implicated in causing tissue damage in diabetic foot ulcers (DFUs), our knowledge of the contribution of the entire microbiome to clinical outcomes is limited. We profiled the microbiome of a longitudinal sample series of 28 people with diabetes and DFUs of the heel in an attempt to better characterize the relationship between healing, infection and the microbiome.
INTRODUCTION
It is generally acknowledged that diabetic foot ulcers (DFUs) present a considerable clinical and economic burden [1, 2] . They have multiple and various overlapping causes, including peripheral artery disease and different modalities of neuropathy. As intact skin provides a natural barrier, ulceration and exposure of nutrient-rich tissues to the surface predisposes to colonization with a wide array of microbes. Clinically apparent infection with known pathogens, such as Staphylococcus aureus, is recognized as an important cause of deterioration of pre-existing DFUs and delayed healing [3, 4] and best practice is to sample DFUs with clinical signs of infection to identify them [5] . However, little is known regarding interactions which may occur within a diverse community of micro-organisms (and/or with the host) which could result in delayed healing, subclinical tissue damage or predisposition to clinical infection.
Advances in high-throughput next generation sequencing have enabled the molecular characterization of entire microbial communities from any particular site, termed the microbiome. Profiling of marker genes, such as the 16S rRNA gene, or sequencing all the genetic material present in a sample provides an overview of the microbiome -including micro-organisms which may be difficult to culture or be present in very low numbers [6] . These large datasets can be analysed with data-mining techniques to uncover relationships between the presence of various groups of microorganisms and clinical variables. In a cross-sectional study of soft tissue samples from 40 people with DFUs, Dowd [7] described a broader spread of taxa than previously identified by culture-based methods, while in a more recent study of 52 surface swabs from non-infected plantar neuropathic DFUs, Gardner and colleagues [8] reported clustering of identified bacterial taxa into three broad groups, demonstrating significant associations between bacterial groups and DFU depth, area and overall quality of glycaemic control. Further insight was provided by a study of 100 subjects with DFUs from whom repeated samples were obtained in a subpopulation [9] . The authors described four different types of bacterial community based on the dominant population of identified bacteria and also studied the extent to which these populations changed. They suggested that more frequent change in community types was a feature of those that healed within 12 weeks of observation.
A deeper understanding of polymicrobial interactions and impact on host tissues could inform risk stratification tools for DFUs and facilitate the design of targeted interventions aimed at altering the colonizing microbiota such as phage therapy. In the setting of infection, this may also enable more selective use of antibiotics where clinically appropriate to reduce broad-spectrum antibiotic exposure. Sequencing costs, technical limitations and analytical barriers are constraining immediate application of microbiome profiling to the management of DFUs. However, developments in sequencing technologies, particularly those with potential point-of-care applications such as Oxford nanopore sequencing, promise to minimize these limitations in the foreseeable future [10] .
The data presented here were collected as a sub-study of a clinical trial investigating the effectiveness of a simple offloading device in patients with DFUs affecting the heel [11] . Swab samples were taken at the time of recruitment and at fortnightly intervals up to a maximum of 24 weeks until DFU healing or withdrawal from the parent study. Associations were sought between clinical measures and the microbiota, both at baseline and over the course of the study. Data available from the parent study provided baseline details of the participants as well as clinical information relating to DFU status at each study visit.
METHODS
Participants in the parent trial were those with diabetes complicated by DFUs on the heel and were randomized to management either with standard good care plus lightweight fibreglass heel casts or with standard good care alone, and were reviewed in a specialist clinical research service every 2 weeks. The results of this parent study have been reported in full elsewhere [11] . The present study was approved by Derby Research Ethics Committee (IRAS ID 137934). Participating centres were selected from those that were recruiting well to the parent study and which agreed to undertake the additional sampling. All participating patients provided additional informed consent. Since no difference in any outcome measure was observed between the intervention and the usual care arms of the parent study, samples from patients in both groups were combined for the present analyses.
Details of sampling and sample handling Samples were obtained using flock swabs and the Z technique after cleansing and sharp debridement of the wound surface. Samples were identified only by study centre and study number. Each swab tip was retained in the collection tube and submerged in a PBS-based buffer solution (MoBio Powersoil Collection Fluid) to maintain constant pH. For transport, the samples were packed in a protective plastic casing with a cold pack, boxed and sealed in a prepaid envelope and posted first class within 24 h to a central microbiology laboratory at Nottingham University Hospitals NHS Trust. Samples were subsequently stored at À80 C until extraction.
DNA extraction DNA was extracted from the whole sample using the MoBio Powersoil Kit (since renamed to DNeasy PowerSoil Kit) as per the manufacturer's guidelines with a pre-extraction homogenization step (4500 r.p.m., 45 sÂ3). DNA was stored at À80
C to await subsequent analysis. The obtained DNA was quantified using the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen) and analysed, in duplicate, on an ABI7500 device (Applied Biosystems).
16S rRNA gene amplification, library preparation and sequencing Amplicons were generated for the V4 region of the 16S rRNA gene using the above extracted DNA as a template. Previously validated primers were used to amplify a 359 bp amplicon of the V4 hypervariable region of the prokaryotic 16S rRNA gene (515F: TCGTCGGCAGCGTCAGATGTG TATAAGAGACAGGTGCCAGCMGCCGCGGTAA, 806R: GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGG-GACTACHVGGGTWTCTAAT) [12] . In total, 237 out of 256 samples received were successfully amplified.
PCR clean-up was performed using AMPure XP beads (Beckman Coulter) before proceeding to index PCR, which attached barcodes to individual samples and Illumina sequencing adapters using the Nextera XT Index Kit, as per Illumina guidelines. Negative controls were included to account for reagent contamination [13] . After index PCR, clean-up was repeated as above and amplicons were individually quantified using an Agilent Bioanalyser prior to normalization and pooling. The barcoded amplicon pool was run on an Illumina MiSeq using 2Â250 bp chemistry. Raw . fastq files were output for subsequent bioinformatics analysis. The sequencing data are publicly available in the European Nucleotide Archive (ENA, accession no. PRJEB28661).
16S rRNA sequence pre-processing and taxonomic assignment DNA sequence data were pre-processed with the mare package [14] in R (R Foundation for Statistical Computing) as follows: paired-end reads were merged with quality filtering and trimmed to a uniform length (290 bp). After chimera filtering and clustering with USEARCH [15] , reads were assigned to taxonomic labels by alignment with the RDP database [16] using UTAX and a confidence level of 0.6. Taxa below this cut off were annotated as unclassified at that taxonomic level and assigned to the next highest available level. Unique reads occurring at a frequency of less than 1 : 100 000 were excluded to avoid operational taxonomic unit (OTU) inflation. Two halophilic genera, Halomonas and Shewanella, were identified from negative controls as possible contaminants and excluded from the analysis.
Oxford nanopore library preparation and sequencing Swab DNA extracts were treated with a NEBNext Microbiome DNA Enrichment Kit (New England Biolabs) to enrich microbial DNA prior to sequencing [17] . Library preparation was performed with a Rapid Low Input by PCR Barcoding Kit (SQK-RLB001; Oxford Nanopore Technologies) and libraries were sequenced on the MinION platform (Oxford Nanopore Technologies). Base calling was performed with Albacore Sequencing Pipeline Software (version 2.1.2; Oxford Nanopore Technologies) with raw .fastq files output for subsequent analysis.
Direct sample sequencing analysis MinION reads were screened against the human genome reference hg19 (GenBank assembly GCA_000001405.1) using Minimap2 [18] to remove host DNA contamination. The resulting non-human sequences were annotated with Centrifuge 1.0.3 [19] using the default database for bacteria and archaea. A minimum hit length of 50 and hit length covering at least 5 % of the reads were used to filter the resulting annotations. For detection of antimicrobial resistance genes, all of the non-human reads for the sample were assembled using Canu 1.7 [20] . The resulting contiguous sequences were assigned a taxonomic identification by Centrifuge and then input to ResFinder 3.0 [21] searching for acquired antimicrobial genes with a 95 % identity threshold.
Statistical and network analysis
Alpha diversity [Inverse Simpson Index (ISI), variation within any one sample] and beta diversity [Bray-Curtis Dissimilarity (BCD), variation between samples] were calculated using the vegan package [22] in R (R Foundation for Statistical Computing), with principal coordinates analysis of BCD and permutational multivariate analysis of variance (PERMANOVA) used for analysis of multivariate microbiota count data. Associations between diversity and clinical categories were tested for using an unpaired t-test or ANOVA after assessing for normality with the ShapiroWilk method.
To enable analysis of changes occurring within individual DFUs over time, samples were assigned to clusters based on taxonomic profile. Sample clusters were created with the default k-means clustering function in R using relative abundances of taxa at the family level with 150 maximum iterations and 10 simulated starts. After examining the relationship between variance explained and cluster number, six clusters were chosen to best represent the data (Fig. S1 , available in the online version of this article).
Once samples had been assigned to one of the six clusters, a Markov model was constructed by counting all cluster transitions over consecutive visits and the counts were converted to proportional probabilities by dividing by the total number of transitions from that cluster. If swab data were unavailable for the subsequent visit, the next available visit was used as the destination cluster. The final cluster for each subject was then used to calculate the probability of transition from each cluster to a healed or unhealed state at the study end. Differences in transition probabilities between healed and unhealed DFUs were calculated using a log likelihood ratio test.
A metabolic complementarity network was created from the MinION data by using the NetSeed pairwise metabolic complementarity index (MCI) previously calculated by Levy and Borenstein for 154 species found in the human microbiome [23, 24] . Briefly, NetSeed requires as input a metabolic network for each species, based on a list of KEGG reactions per genome available from the Integrated Microbial Genomes project (IMG; http://img.jgi.doe.gov) and generated as described previously [25] . The seed set of the network identified by NetSeed represents exogenously acquired compounds which appear as reaction substrates but not products. The MCI is a pairwise comparison of the proportion of the seed set from one species which are products but not seeds in a partner species network, thereby representing complementary by-products. The most closely related species for which an MCI score was available was identified for each of the most abundant taxa in the DFU. These scores were used to create a network with each species represented by a node, and each pairwise MCI score with a value greater than 0.5 represents a directed edge towards the species from which benefit is predicted to be derived.
RESULTS

DFU characteristics and microbiota composition
In total, 237 samples were analysed from the index DFU from 28 individuals, of which eight healed during the study period (Table S1 ). The median (interquartile range, IQR) age of the participants was 70.5 (60-77) years. Twenty Characterization of the microbiota of each sample based on 16S rRNA gene sequencing identified 63 distinct genera from 37 families, of which the 10 most abundant families accounted for 89.6 % of the overall composition (Table S2) . The most abundant taxonomic groups were Corynebacterium (22.7 %), Staphylococcus (15.2 %), unclassified Enterobacteriaceae (10.6 %), Anaerococcus (6.4 %), Pseudomonas (6.1 %) and Streptococcus (4.6 %). The majority of the variation between the samples could be explained by subject, indicating that the microbiome of any one DFU tended to be distinct from any other (PERMANOVA, 63.7 % variance explained, P<0.001). There was no correlation between baseline DFU area or National Pressure Ulcer Advisory Panel (NPUAP) depth score and microbial diversity (alpha diversity, ISI).
Clustering analysis indicated that samples could be separated into six distinct groups based on broad compositional differences, with one or two highly abundant taxa characterizing each cluster (Fig. S2 ). Clusters were assigned a letter based on dominant taxa; cluster 1 (n=20, Pseudomonaceae 58.1 % -P), cluster 3 (n=49, Corynebacteriaceae 68.3 % -C), cluster 4 (n=17, Micrococcaceae 87.2 % -M) and cluster 6 (n=34, Staphylococcaceae 74.6 % -S) were relatively homogeneous while cluster 2 (n=61, Enterobacteriaceae 33.4 % -E) and cluster 5 (n=56, Clostridiales Incertae Sedis XI 38.2 % and other anaerobes~20 % -A) exhibited greater taxonomic diversity.
Variations in microbial community dynamics between healing and non-healing DFUs We sought to investigate whether the microbiotas of nonhealing DFUs were different to healing DFUs in both overall composition and changes over time.
Of the 51 samples taken from the eight DFUs which healed, the majority of samples fell into either the C (17/51, 33.3 %) or S (11/51, 21.6 %) clusters while of the 186 samples taken from 28 unhealed DFUs, the E (52/186, 28.0 %) and A (48/ 186, 25.8 %) clusters were most frequently represented. Mean baseline alpha diversity in healing DFUs was 2.3 (±0.9) compared to 2.9 (±1.5) for those that did not heal, but this difference was not statistically significant (P=0.19).
For each DFU, the transition in the microbiota between clusters over subsequent visits was used to develop a Markov model (Fig. S3 and Table S3 ). The microbiota of individual DFUs tended to remain within the same cluster over subsequent visits with probabilities ranging from 53 % of samples in the S cluster to 71 % in the M cluster. No transitions were observed between the S and P clusters while transitions frequently occurred from the A to E cluster (probability=20 %) although less frequently from E to A (8 %).
Specific features of healing and non-healing DFUs were identified from the changes in the microbiota profiles over time. Non-healing DFUs with profiles of either E or A were less likely to transition away from these to other clusters compared with healing DFUs (probably per visit: nonhealing 21 % vs healing 59 %, log likelihood ratio 9.56, P=0.008). In DFUs which healed, high rates of transition were observed from E towards several clusters, particularly S (33 %) and C (22 %), so that in the final visit before healing, 75 % of healed DFUs had a microbiota profile of either S (3/8) or C (3/8) with only one each in the E and P clusters and none in either M or A.
Individual profiles from DFUs which were consistent with these overall trends are illustrated in Fig. 1 . In Fig. 1(a) , the DFU was persistently colonized by a high proportion of Corynebacterium and Staphylococcus with two episodes of infection treated with co-amoxiclav before finally healing. Fig. 1(b) Fig. 1(c) , Enterobacteriaceae and anaerobes are highly abundant during several visits before gradual replacement with Pseudomonas pre-healing. Fig. 1(d) provides an example of a non-healing DFU where various anaerobes and Enterobacteriaceae are present throughout.
Changes in the microbiota associated with infection and antibiotic therapy Forty-six per cent (13/28) of subjects had at least one episode of clinical infection, with a total of 20 discrete episodes of infection identified covering 44 visits.
Infection and antibiotic use often co-occurred such that their relative associations with sample diversity could not be readily distinguished. Overall, samples from infected DFUs exhibited lower microbial diversity than those from uninfected DFUs (infected 2.2±0.9 vs. uninfected 3.1±1.5, P=1Â10
À6
), while diversity also appeared to be lower for visits where subjects were receiving antibiotic therapy (antibiotics 2.4±1.2 vs. no antibiotics 3.1±1.5, P=0.001). Analysing the contribution of both variables indicated that infection was likely to be a greater contributor to the fall in diversity (ANOVA, F=14.0, P<0.001) than antibiotic exposure (F=2.1, P=0.15).
To further investigate the changes in microbial diversity associated with individual episodes of infection, samples from visits occurring either immediately preceding, during or following an episode of clinical infection were aligned and the microbial diversity was plotted. This demonstrated a reduction in microbial diversity at the onset of infection with a corresponding recovery in diversity beginning from the final visit where infection was noted clinically (Fig. 2) .
Across all samples taken from infected DFUs, clusters E (24/44, 54.5 %) and C (11/44, 25.0 %) were the most prevalent overall, and this was the same for the first visit of each episode of infection (cluster E: 10/20, 50.0 %; cluster C: 4/ 20, 20.0 %). Despite the recognized importance of Staphylococcus aureus as a pathogen in this context, only one DFU had a high proportion of Staphylococcus at infection onset, falling into the S cluster. There were three and two episodes of infection beginning with profiles in the P and A clusters, respectively.
Further individual profiles demonstrating temporal changes in the microbiota associated with episodes of clinical infection are shown in Fig. 3 . In the DFU profile shown in Fig. 3  (a) , colonization at baseline with a mixture of Kocuria and other Micrococcaceae was observed with an initial alpha diversity index of 1.96. At visit 7, this fell to 1.15 following the emergence and expansion of staphylococci within the DFU, associated with an episode of clinical infection. After commencement of anti-staphylococcal antibiotic therapy (flucloxacillin), the profile reverted to the taxa which were originally dominant.
Several episodes of infection occurred in the DFU shown in Fig. 3(b) , which had a high baseline diversity index of 4.79, falling to 1.37 at visit 5 due to an expansion of streptococci, with associated clinical infection from visits 3 to 6. Recovery of microbial diversity to 4.6 at visit 7 with emergence of Enterobacteriaceae and later Pseudomonas were also observed.
In Fig. 3(c) , a DFU colonized with a high proportion of anaerobes over successive visits from 4 to 6 with high Example of a nonhealing DFU persistently colonized by mixed anaerobes and Enterobacteriaceae. Infection, antibiotic exposure or high microbial diversity is indicated by red on the colour map, while absence of infection, antibiotic exposure or low microbial diversity is indicated by green. DFU cluster designations: P=Pseudomonaceae, E=Enterobacteriaceae, C=Corynebacteriaceae, S=Staphylococcaceae, A=anaerobes, M=Micrococcaceae, N=non-healing at study end, H=healed. diversity (visit 6 : 7.81) underwent a dramatic reduction in diversity during an episode of clinical infection at visit 10 (2.58) accompanied by an expansion of Anaerococcus and Peptonophilus. After a course of co-amoxiclav, the anaerobes were no longer abundant at visit 11, having been replaced by Enterobacteriaceae.
The profile shown in Fig. 3(d) shows a DFU colonized by Enterobacteriaceae, Pseudomonas and Corynebacterium. Onset of infection at visit 8 and empirical treatment with doxycycline was followed later by expansion of streptococci from visit 8 to 9. After a second course of ciprofloxacin and metronidazole, diversity was markedly reduced from 3.8 at visit 9 to 1.1 at visit 11 as Corynebacterium replaced the other taxa to become the dominant organism in the DFU.
In addition to the cases described above, abrupt changes were also noted in certain DFUs without any obvious cause such as antibiotic exposure or clinical infection. In other cases the clinical diagnosis of infection was documented but there were no obvious associated changes in the microbiota (Fig. S4) .
Direct sample sequencing identifies individual species and resistance genes Short-read sequencing of 16S rRNA amplicons enables high-throughput community profiling but is limited by taxonomic resolution and does not provide any additional information about the genetic capability of a community. To complement the 16S profiles, we conducted longer read sequencing using the Oxford Nanopore MinION on the swab DNA extracts for the profile shown in Fig. 3(b) . This profile was chosen as it was one of the most diverse, containing a mixture of taxa including streptococci, Enterobacteriaceae, Pseudomonas and several strict anaerobes.
Seven samples were sequenced from alternate visits (1, 3, 5, 7, 9, 11 and 13). Despite a microbiome enrichment step, only three samples yielded >1000 reads once host DNA sequences had been discarded (V3 16 900, V5 2353, V9 2127). After performing sequence annotation with the taxonomic classifier, Centrifuge [19] , and applying strict cut-offs to the output to optimize the accuracy of taxonomic identification, only a small proportion of reads were eventually assigned to a bacterial species (V3 1548, V5 426, V9 172). Taxa identified from V3 compared well to the 16S profile (Fig. 4a) . While read numbers were low for V5 and V9, the species identified were also consistent with the 16S results, including Streptococcus anginosus (V5, V9), Escherichia coli (V5, V9), Enterococcus faecalis (V5), Staphylococcus aureus (V5), Bacteroides fragilis (V9) and Porphyromonas asaccharolytica (V9).
Analysing the V3 sample for the presence of antimicrobial resistance genes using the ResFinder tool [26] identified tet, erm and cfx genes. Assembling the sequences from this sample and performing taxonomic annotation on the resulting assembly enabled the matching of tetM, ermA and ermB to Streptococcus anginosus and cxfA and tetQ to Prevotella intermedia based on the presence of these genes in continuous DNA sequences with a high-quality taxonomic assignment.
Finally, using the more detailed taxonomic profile created from this DFU, we compiled a network of potential interspecies interactions based on an MCI previously calculated by Levy et al. [23] using the NetSeed algorithm [24] (Fig. 4b) . Higher MCI scores indicate a species is predicted to derive metabolic benefit from the metabolic by-products of the partner species. The strict anaerobes, particularly Porphyromonas asaccharolytica, are predicted to derive benefit from a number of other species, particularly Escherichia coli and Pseudomonas aeruginosa, whereas Escherichia coli is predicted to confer benefit on all the strict anaerobes, Enterococcus faecalis and Streptococcus anginosus, but may not itself derive much metabolic benefit from the presence of these species.
DISCUSSION
We have characterized the variation in the microbiota of 28 DFUs using a high-resolution longitudinal sampling Streptococcus followed by treatment with ciprofloxacin after visit 9 and accompanying elimination of Streptococcus and Enterobacteriaceae. Infection, antibiotic exposure or high microbial diversity is indicated by red on the colour map, while absence of infection, antibiotic exposure or low microbial diversity is indicated by green. DFU cluster designations: P=Pseudomonaceae, E=Enterobacteriaceae, C=Corynebacteriaceae, S=Staphylococcaceae, A=anaerobes, M=Micrococcaceae, N=non-healing at study end, H=healed.
approach over a 6-month period, or until DFU healing. Successive longitudinal sampling is particularly valuable in this context as we were able to observe changes in the DFU microbiota occurring over short time frames and in conjunction with clinical events such as impending healing, infection or antibiotic administration.
The most abundant taxa identified in this study were similar to those found in other molecular studies of DFUs, although the proportions vary between studies [8, 9, 27] . We observed a dominance of Gram-positive organisms including Corynebacteria (22.7 %), staphylococci (15.2 %) and anaerobic members of the families Clostridiales Incertae Sedis X (total 13.4 %, including Anaerococcus, Finegoldia and Peptinophilus) and Micrococcaceae (7.9 %), with a lower abundance of Gram-negative organisms, predominantly the family Enterobacteriaceae (11.5 %) and Pseudomonas (6.1 %). By comparison, Wolcott et al. [27] identified Staphylococcus aureus (15.0 %) and Fig. 3(b) , comparing taxonomic identifications based on Illumina 16S rRNA and Oxford Nanopore MinION direct sample sequencing taken during an episode of clinical infection at visit 3. (b) Potential network of inter-species interaction for representative species based on this DFU profile, created using the MCI [23] . Edges are shown for all scores greater than 0.5. Higher scores are reflected by greater edge thickness with arrows directed towards the partner species from which metabolic benefit is predicted to derive.
Staphylococcus epidermidis (10.7 %) as the most abundant species in 910 DFUs of all types using 16S amplicon pyrosequencing with high proportions of Pseudomonas aeruginosa, Corynebacterium spp., Enterococcus spp., Finegoldia magna and Anaerococcus vaginalis also present. The proportions observed here are likely to reflect the patient group and DFU type selected for the parent study.
There are likely to be a large number of factors which are responsible for shaping the microbiota of an individual DFU. These will include bacteria already present on intact skin and elsewhere in the body prior to ulceration, as well as the microenvironment influenced by oxygen tension, glycaemic control, chronicity of the wound and historical antibiotic exposure [8, 28, 29] . This would explain why samples from any one DFU tended to be similar to each other, but often varied greatly in composition to other DFUs. By contrast, the gut microbiota is heavily influenced by dietary intake and tends to be composed of a core group of taxa in individuals who share a similar diet [30] .
To overcome the challenge of comparing a heterogeneous group of samples from a limited DFU population, we used a clustering approach similar to that employed in other molecular studies of DFUs [8, 9] . Clustering at the family level facilitated the grouping of organisms with overlapping genomic content and growth requirements such as the variety of closely related anaerobes within the Clostridiales Incertae Sedis X. The resulting six clusters were relatively homogeneous, consistent with the most abundant taxa identified and captured a significant proportion of the overall variation in the data. Repeat sampling from individual DFUs yielded profiles from the same cluster on at least 50 % of visits, consistent with the observation that individual DFUs tended to have unique profiles and retained the same combinations of taxa over time.
Impaired healing of DFUs is influenced by a variety of factors, notably ischaemia and neuropathy, but also subtle cellular deficits, particularly impaired leucocyte function and alterations in the normal inflammatory response [4, [31] [32] [33] . There is a growing body of evidence that the composition of the chronic wound microbiome may also have an impact, but the possible mechanisms for this are not well understood. In a murine wound model comparing wild-type to diabetic mice, Grice et al. [34] observed delayed healing in diabetic mice with differences in gene expression associated with the immune response, and increased abundance of Staphylococcus, Aerococcus and taxa within the Enterobacteriaceae and Porphyromonadaceae. In a compelling study, Wolcott et al. [35] sampled the microbiota from 43 chronic wounds and observed that 83 % of these interfered with healing when transplanted into a murine chronic wound model.
In this study, we observed a tendency towards persistent colonization with a heterogeneous population of bacteria including Enterobacteriaceae and several groups of Grampositive and Gram-negative anaerobes in DFUs which failed to heal. DFUs which healed tended to be colonized with high proportions of Gram-positive aerobes, particularly staphylococci and corynebacteria, prior to healing. An obvious explanation for these findings is that the microbiota are simply determined by the DFU environment; chronic nonhealing wounds promote the growth of organisms preferring moist sites while DFUs which have almost healed support organisms commonly found on intact skin. The alternative possibility that must also be considered, however, particularly in light of other studies in this area, is that colonization with certain combinations of microbes may itself be a contributor to delayed healing. In a murine chronic wound model, Dalton et al. [36] found that a polymicrobial mixture of Gram-positive and Gram-negative aerobes and anaerobes was associated with delayed healing compared to wounds colonized with a single organism. Loesche et al. [9] also studied longitudinal profiles of the microbiota in DFUs and while they did not identify specific groups of bacteria associated with poor healing, they did observe that non-healing DFUs tended to have a stable microbiome with less variation over time than healing DFUs.
In addition to environmental factors, competition for nutrients and metabolic synergy between microbes is another key determinant of community composition [21] . Analysing the predicted metabolic overlap between species co-occurring in one DFU in this study indicated that strict anaerobes are likely to be the principal beneficiaries of such metabolic overlap. Anaerobes such as Porphyromonas benefit from poor tissue oxygenation in diabetes and possibly also increased levels of metabolic substrates such as alphaketoglutarate [37, 38] . They may also benefit from microanaerobic climates created by other bacteria lowering the redox potential, forming surface layers including biofilms and exchange of metabolic by-products. Studies of the microbiome in periodontal disease have demonstrated the importance of groups of organisms, including anaerobes, working together to impair the host response, degrade connective tissue and promote chronic inflammatory states [39] .
The diversity of individual samples tended to be lower during episodes of clinical infection and in patients on antibiotic therapy. In some instances this appeared to indicate the proliferation of potentially pathogenic organisms which may have resulted in the clinical symptoms observed. Alternatively, it could be that inflamed wounds represent a changed local environment in which certain bacteria are able to flourish while others are not. Certain bacteria, such as Escherichia coli, are able to use inflammatory mediators, for example nitric oxide, as metabolic substrates potentially giving them a survival advantage in pro-inflammatory environments [40] . Interactions between microbes may result in the promotion or suppression of certain species with virulence potential. Another possible mechanism by which community dynamics may influence the onset of infection is through modulation of virulence potential by inter-species interactions. Ramsey et al. observed that Corynebacterium striatum was capable of interfering with quorum sensing in Staphylococcus aureus with the effect of suppressing virulence factor production [41] . While high proportions of staphylococci were only observed in one in 20 cases of developing infection, it is possible that proliferation of other species may have altered virulence factor expression by less abundant pathogens such as Staphylococcus aureus, resulting in tissue damage, inflammation and clinically apparent infection.
16S rRNA amplicon sequencing enables the identification of organisms that are difficult to isolate with conventional culture, while giving an estimate of the proportion of bacterial taxa present in the sample. Despite potential high throughput and low cost, the principal limitation of shortread sequencing is that taxa cannot be reliably identified to the lowest taxonomic levels, particularly species but also genus in some cases. As higher level taxonomic groupings, such as the family Enterobacteriaceae, can contain a wide range of organisms with greatly differing virulence potential, this is a significant drawback. Nonetheless, this form of molecular survey is capable of yielding important insights into the bacterial community dynamics of a DFU and how this relates to clinical events, more so than phenotypic testing. Microbiota profiles were often similar over multiple visits, both in the most abundant taxa identified and in their relative proportions. This suggests that the approaches used for sampling, extraction, amplification and sequencing were likely to be relatively consistent between samples.
To complement the 16S analysis, we also analysed swab DNA extracts directly with Oxford nanopore sequencing technology, which is the first time to our knowledge that this has been applied to diabetic wounds. Sequencing the total pool of the DNA in a sample enabled greater taxonomic resolution and identification of antibiotic resistance genes. The amount of information which could be determined from a sample appeared to be directly proportional to the ratio of host to bacterial DNA recovered, as any host DNA sequenced reduced bacterial read depth. The high proportion of host DNA in many of the samples limited a comprehensive characterization of the microbiota. Technical challenges to be overcome include the optimization of sample extraction methods and reduction in the proportion of host DNA, although the capacity for rapid sequencing is an appealing prospect for diagnostic utility.
Given the longitudinal study design and need for fortnightly sampling, ulcer base swabs were chosen over tissue sampling. Aside from drawbacks of the sequencing technologies used, this is another potential study limitation as surface swabs may not detect the invasion and proliferation of bacteria in tissue layers during infection. In a cross-sectional study of wound swab versus tissue sampling, Nelson et al. detected a higher proportion of tissue samples containing at least one recognized pathogen (86.1 %) vs. swabs (70.1 %) with fewer less pathogenic organisms in tissue [42] . Host DNA proportions are likely to be even higher in tissue samples than from swabs, although longitudinal microbiota characterization from tissue samples could potentially give clearer insight into the dynamics of infection if these considerable practical and technical difficulties can be overcome.
This study has yielded important information on the microbiology of difficult-to-heal DFUs of the heel, including differences in microbial diversity and changes over time in infected, healing and non-healing DFUs. While heel ulcers are a subtype of DFUs, they represent a wide range of DFU types from the small and superficial to the deep and anaerobic. We anticipate that building on this and similar studies by analysing a greater number and employing a wide range of sequencing strategies, including full metagenomics and transcriptional analysis, will add to our understanding of the mechanisms underlying non-healing DFUs, with implications for future basic and translational research studies in this field.
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